A p34cdc2 survival checkpoint in cancer
Daniel O’ConnorBoyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven, Connecticut 06536, USANathan R. WallBoyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT 06536 USAAndrew C.G. PorterGene Targeting Group, Imperial College of Medicine, Hammersmith Hospital, London W12 0NN, United KingdomDario C. AltieriBoyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT 06536 USA
2002en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references